Simulations Plus, Inc. (SLP)
NASDAQ: SLP · IEX Real-Time Price · USD
46.86
+0.68 (1.47%)
At close: Jul 2, 2024, 4:00 PM
43.15
-3.71 (-7.92%)
After-hours: Jul 2, 2024, 7:58 PM EDT
Simulations Plus Revenue
Simulations Plus had revenue of $64.67M in the twelve months ending February 29, 2024, with 18.86% growth year-over-year. Revenue in the quarter ending February 29, 2024 was $18.31M with 16.22% year-over-year growth. In the fiscal year ending August 31, 2023, Simulations Plus had annual revenue of $59.58M with 10.52% growth.
Revenue (ttm)
$64.67M
Revenue Growth
+18.86%
P/S Ratio
14.48
Revenue / Employee
$336,813
Employees
192
Market Cap
936.49M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Aug 31, 2023 | 59.58M | 5.67M | 10.52% |
Aug 31, 2022 | 53.91M | 7.44M | 16.01% |
Aug 31, 2021 | 46.47M | 4.88M | 11.73% |
Aug 31, 2020 | 41.59M | 7.62M | 22.43% |
Aug 31, 2019 | 33.97M | 4.30M | 14.51% |
Aug 31, 2018 | 29.67M | 5.53M | 22.90% |
Aug 31, 2017 | 24.14M | 4.17M | 20.86% |
Aug 31, 2016 | 19.97M | 1.66M | 9.05% |
Aug 31, 2015 | 18.31M | 6.85M | 59.80% |
Aug 31, 2014 | 11.46M | 1.39M | 13.80% |
Aug 30, 2013 | 10.07M | 622.16K | 6.58% |
Aug 31, 2012 | 9.45M | 709.87K | 8.12% |
Aug 31, 2011 | 8.74M | -1.97M | -18.42% |
Aug 31, 2010 | 10.71M | 1.57M | 17.16% |
Aug 31, 2009 | 9.14M | 175.30K | 1.95% |
Aug 31, 2008 | 8.97M | 110.16K | 1.24% |
Aug 31, 2007 | 8.86M | 3.00M | 51.28% |
Aug 31, 2006 | 5.86M | 1.10M | 23.20% |
Aug 31, 2005 | 4.75M | -454.03K | -8.72% |
Aug 31, 2004 | 5.21M | -278.05K | -5.07% |
Aug 31, 2003 | 5.48M | 1.04M | 23.42% |
Aug 31, 2002 | 4.44M | 529.26K | 13.52% |
Aug 31, 2001 | 3.91M | 285.03K | 7.85% |
Aug 31, 2000 | 3.63M | 162.75K | 4.69% |
Aug 31, 1999 | 3.47M | 821.65K | 31.06% |
Aug 31, 1998 | 2.65M | 152.06K | 6.10% |
Aug 31, 1997 | 2.49M | -107.69K | -4.14% |
Aug 31, 1996 | 2.60M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Avanos Medical | 680.10M |
MiMedx Group | 334.51M |
Maravai LifeSciences Holdings | 274.10M |
Gyre Therapeutics | 140.62M |
BioLife Solutions | 137.30M |
Tango Therapeutics | 37.23M |
Liquidia | 15.97M |
Autolus Therapeutics | 10.50M |
SLP News
- 5 hours ago - Simulations Plus Reports Third Quarter Fiscal 2024 Financial Results - Business Wire
- 12 days ago - Simulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit - Business Wire
- 14 days ago - Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date - Business Wire
- 20 days ago - QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus - Business Wire
- 20 days ago - Simulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development Continuum - Business Wire
- 5 weeks ago - Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference - Business Wire
- 6 weeks ago - Simulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software - Business Wire
- 3 months ago - U.S. FDA Renews DILIsym® Software Licenses for 7th Year - Business Wire